Psychosocial Support for Rett Syndrome Caregivers
This study is adapting a support program called "Caregiver Speaks" for parents and caregivers of individuals with Rett syndrome. Rett syndrome is a rare, complex neurological disorder that requires intensive care, which can be very challenging for families. The program, delivered online through a private social media platform, aims to provide psychological support to these caregivers. Participants in this study will be receiving Daybue (trofinetide) as part of their routine medical care, but the study itself does not manage this medication. Researchers want to see if this adapted support program is practical to use and helpful for caregivers, specifically looking at its impact on their psychological well-being. The study plans to enroll 60 participants and is currently unclear regarding its recruitment status. You can join if you are an adult caregiver (18 years or older) of someone with a confirmed diagnosis of Rett syndrome, can speak English, and are willing to participate in a 6-week online program.
- Study design
- This is an interventional study with a planned enrollment of 60 participants. It is not specified if it is randomized or blinded.
- What's involved
- You would participate in a 6-week online psychosocial intervention delivered via a private social media platform.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcome is measured immediately after the 6-week intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Adapting a Psychosocial Support Intervention for the Rett Syndrome Community
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Feasibility of Intervention Measure (FIM)Immediately post-intervention (6 weeks)
Feasibility of the Caregiver Speaks-RTT intervention assessed by caregiver recruitment, retention, session participation, and completeness of outcome data. Feasibility benchmarks include ≥80% intervention engagement, ≥80% retention through completion, and \<20% missing baseline or post-intervention data, measured using the Feasibility of Intervention Measure (FIM) and participation metrics. 1 to 5 (average score across 4 items; alternatively 4 to 20 if summed).